医学
结直肠癌
全直肠系膜切除术
放射科
放化疗
远处转移
新辅助治疗
磁共振成像
转移
放射治疗
癌症
内科学
乳腺癌
作者
Natally Horvat,Camila Carlos Tavares Rocha,Brunna Clemente Oliveira,Iva Petkovska,Marc J. Gollub
出处
期刊:Radiographics
[Radiological Society of North America]
日期:2019-03-01
卷期号:39 (2): 367-387
被引量:240
标识
DOI:10.1148/rg.2019180114
摘要
Rectal cancer is prone to local recurrence and systemic metastasis. However, owing to improvements in TNM staging and treatment, including a more widespread use of rectal MRI and increased radiologist awareness of the key rectal cancer TNM staging features, the mortality rate of rectal cancer has been declining over the past few decades in adults over 50 years of age. Currently, rectal MRI plays a key role in the pre- and posttreatment evaluation of rectal cancer, assisting the multidisciplinary team in tailoring the most appropriate treatment option. The benefits achieved with rectal MRI are strictly dependent on obtaining good-quality images, which is important for the characterization of the main anatomic structures and their relationship with the tumor. In primary staging, rectal MRI helps the radiologist (a) describe the tumor location and morphology, (b) provide its T and N categories, (c) detect the presence of extramural vascular invasion, and (d) identify its relationship with surrounding structures, including the sphincter complex and involvement of the mesorectal fascia. These features help diagnose locally advanced rectal tumors (categories T3c-d, T4, N1, and N2), for which neoadjuvant chemoradiotherapy (CRT) is indicated. In restaging after neoadjuvant CRT, in addition to reassessing the features noted during primary staging, rectal MRI can help in the assessment of treatment response, especially with the emergence of nonsurgical approaches such as “watch and wait.” ©RSNA, 2019
科研通智能强力驱动
Strongly Powered by AbleSci AI